Canada Life
GBT

Canada Life’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Canada Life’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,336
Closed -$107K – 2406
2022
Q2 		$107K Buy
3,336
+659
+25% +$19.3K ﹤0.01% 1910
2022
Q1 		$99K Sell
2,677
-594
-18% -$17.8K ﹤0.01% 2002
2021
Q4 		$95K Hold
3,271
– – ﹤0.01% 2022
2021
Q3 		$84K Hold
3,271
– – ﹤0.01% 2096
2021
Q2 		$114K Hold
3,271
– – ﹤0.01% 2055
2021
Q1 		$132K Sell
3,271
-816
-20% -$37.5K ﹤0.01% 2040
2020
Q4 		$177K Hold
4,087
– – ﹤0.01% 1995
2020
Q3 		$225K Hold
4,087
– – ﹤0.01% 1876
2020
Q2 		$257K Hold
4,087
– – ﹤0.01% 1847
2020
Q1 		$209K Hold
4,087
– – ﹤0.01% 1801
2019
Q4 		$323K Buy
+4,087
New +$242K ﹤0.01% 1820
2019
Q3 		– Sell
-7,451
Closed -$391K – 2502
2019
Q2 		$391K Buy
7,451
+688
+10% +$39.5K ﹤0.01% 1852
2019
Q1 		$357K Hold
6,763
– – ﹤0.01% 1729
2018
Q4 		$268K Buy
6,763
+1,794
+36% +$67.2K ﹤0.01% 1854
2018
Q3 		$189K Hold
4,969
– – ﹤0.01% 1994
2018
Q2 		$224K Buy
4,969
+1,469
+42% +$66.9K ﹤0.01% 1944
2018
Q1 		$169K Hold
3,500
– – ﹤0.01% 2010
2017
Q4 		$137K Hold
3,500
– – ﹤0.01% 2071
2017
Q3 		$103K Hold
3,500
– – ﹤0.01% 2144
2017
Q2 		$96K Hold
3,500
– – ﹤0.01% 2136
2017
Q1 		$129K Buy
+3,500
New +$88.1K ﹤0.01% 2030

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Life's GBT Position: Q3 2022 in Review

Canada Life sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 3,336 shares — an estimated $107K sold.

Canada Life first reported a position in GBT in Q1 2017 and held it in 21 quarters. The position peaked at $391K in Q2 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Canada Life reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Canada Life sold 3,336 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $107K.
  • Canada Life first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 21 quarters.
  • Canada Life's Global Blood Therapeutics, Inc. position peaked at $391K in Q2 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Canada Life's 13F filing for Q3 2022, filed 1 Nov 2022.